Michael Hayden

Michael Hayden

Founder presso 89BIO, INC.

Patrimonio netto: 12 M $ in data 29/02/2024

72 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Michael R.
Hayden
is an entrepreneur who founded 7 companies, including: Xenon Pharmaceuticals, Inc., Aspreva Pharmaceuticals Corp.
and 89bio, Inc. Currently, he occupies the position of Chief Executive Officer & Director at Prilenia Therapeutics BV (which he founded in 2018), Scientific Director at Canadian Genetics Diseases Network, Venture Partner at Forbion Capital Partners Management Holding BV and Venture Advisor at Andera Partners SCA.
Dr. Hayden is also Director-Translational Laboratory at National University of Singapore, Professor at the University of British Columbia, Member of American Society of Clinical Investigation and Director & Program Director at Translational Laboratory in Genetic Medicine and on the board of 5 other companies.
In the past Michael R.
Hayden
held the position of President & Chief Scientific Officer at GlobaR&D Co.,Ltd, Chief Scientific Officer at Teva Pharmaceutical Industries Ltd., Independent Director at Xenon Pharmaceuticals, Inc. (he founded the company in 1996), Director at American Society of Human Genetics, Director at Aspreva Pharmaceuticals Corp.
and Director at Centre for Molecular Medicine & Therapeutic.
He received an undergraduate degree and a doctorate from the University of Cape Town.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
22/09/2023 1 441 642 ( 0.49% ) 7 M $ 29/02/2024
01/02/2024 246 430 ( 0.27% ) 3 M $ 29/02/2024
17/07/2023 32 219 ( 0.02% ) 1 M $ 29/02/2024
13/11/2023 39 973 ( 0.04% ) 86 970 $ 29/02/2024

Posizioni attive di Michael Hayden

SocietàPosizioneInizio
IONIS PHARMACEUTICALS, INC. Director/Board Member 24/09/2018
89BIO, INC. Founder 01/04/2018
ABCELLERA BIOLOGICS INC. Director/Board Member 01/10/2019
OXFORD BIOMEDICA PLC Director/Board Member 15/07/2021
Consultant / Advisor 01/01/2018
Private Equity Investor 31/03/2022
Founder 01/10/2018
National University of Singapore Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal 01/01/1992
░░░░░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Tutte le posizioni attive di Michael Hayden

Precedenti posizioni note di Michael Hayden

SocietàPosizioneFine
░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Michael Hayden

Formazione di Michael Hayden

University of Cape Town Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael Hayden

Relazioni

100 +

Relazioni di 1° grado

27

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa8
TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Health Technology

IONIS PHARMACEUTICALS, INC.

Health Technology

OXFORD BIOMEDICA PLC

Health Technology

XENON PHARMACEUTICALS INC.

Health Technology

MANY BRIGHT IDEAS TECHNOLOGIES INC.

Health Services

AURINIA PHARMACEUTICALS INC.

Health Technology

ABCELLERA BIOLOGICS INC.

Health Technology

89BIO, INC.

Health Technology

Aziende private16

Health Technology

Health Technology

Finance

Commercial Services

Finance

Miscellaneous

Commercial Services

American Society of Clinical Investigation

Commercial Services

Commercial Services

Centre for Molecular Medicine & Therapeutic

Health Technology

Translational Laboratory in Genetic Medicine

Commercial Services

Health Technology

GlobaR&D Co. ,Ltd

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Michael Hayden